HINODE study: haemophilia A in infancy and newborns – protocol for a prospective, multicentre, observational study evaluating the coagulation potential and safety of emicizumab prophylaxis

HINODE study: haemophilia A in infancy and newborns – protocol for a prospective, multicentre, observational study evaluating the coagulation potential and safety of emicizumab prophylaxis

Introduction Emicizumab prophylaxis is approved for people of all ages with haemophilia A (HA) including infants and children. Although previous studies have demonstrated the efficacy and tolerability of emicizumab in infants with HA, real-world data on emicizumab use in infants are limited. The Hae...

Full description

Saved in:
Bibliographic Details
Main Authors: Shouichi Ohga, Hirosuke Inoue, Keiji Nogami, Masahiro Takeyama, Masataka Ishimura, Daisuke Nosaka, Keisuke Iwasaki, Chika Mitsui
Format: Article
Language:English
Published: BMJ Publishing Group 2024-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/12/e087556.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items